Patrick F. Kelly - Apr 13, 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role
SVP, Chief Medical Officer
Signature
/s/ Jeannette Potts, as Attorney-in-Fact
Stock symbol
FMTX
Transactions as of
Apr 13, 2022
Transactions value $
$75,750
Form type
4
Date filed
4/14/2022, 06:10 PM
Previous filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction FMTX Common Stock Options Exercise $75.8K +15K +16.69% $5.05 105K Apr 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FMTX Stock Option (Right to Buy) Options Exercise $0 -15K -21.39% $0.00 55.1K Apr 13, 2022 Common Stock 15K $5.05 Direct F1

Explanation of Responses:

Id Content
F1 A total of 70,134 shares subject to an employee stock option were granted on November 21, 2019. 25% of the shares subject to this stock option vested on November 21, 2020, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.